Subscribe Become an Author Sign Up Log In
Private Company

Website

Contact us at info@biopharmatrend.com to request profile updates/corrections. You must be an official company representative to do so (only requests from corporate emails are accepted).

Numerate

Private

About

We apply our novel AI based platform to small molecule chemical design challenges to increase speed and success while reducing the cost

Year Founded
2007
Geography
United States of America based
Funding
$17.4 M
Field/area focus
Chemistry
Research papers
1
Patents
3
Business model
  • Operations Service
  • Own Drug Discovery Programs
Therapeutic focus
  • Cardiovascular
  • Neuroscience
  • Oncology
Product type
  • Small molecules
Research focus
  • Preclinical Development

Investing history

2014Series B8.2
2009Series B5.5
2008Series A1.1
2008Series A2.6

Industry Partnerships

YearPartnerFocus
2011Boehringer Ingelheim
2012Merck
2017Takeda
2019Lundbeck PharmaceuticalsIdentification of clinical candidates for the treatment of disorders in the central nervous system, including depression, psychosis, seizure and neurodegenerative disorders.

Posts Mentioning This Company

New Tools, Products and Technologies
Biopharma Insights
Biopharma Insights
White Papers And Industry Reports